Archives des Expertise

Home
About us

About PhinC

Founded in 2008, PhinC was established with a clear mission: to provide innovative solutions that accelerate and de-risk drug development.

Our history

Our values

Our foundations

Our vision
Expertise

Quantitative modeling at the heart of every stage of drug development

Pharmacological modeling enables us to anticipate, rationalize and secure key decisions throughout development.

Read more ➜

MIDD Strategy

Expert advice

By phase

Lead Optimization

Preclinical

Phase I

Phase II

Phase III

Filing

Solutions

PBPK - PBBM Modeling

Quantitative Systems Pharmacology (QSP)

PK NCA – CDISC

PopPK PD Modeling

QT/QTc Analysis

Clinical Trial Simulation

Integrated Phase I Solutions

Applications

First in Human (FiH)

Drug Drug interactions (DDI)

Special populations

See case studies ➜

Compliance

Quality standards

Regulatory support
Resources

Resources

Through expert analyses, field experience, and concrete case studies, our teams illustrate how modeling drives smarter decisions, mitigates risk, and enhances the efficiency of drug development programs.
Careers
Get in touch
Client area

Publication: Development of a PBPK Model for ADC (oncology)

A first-in-class PBPK model for CLDN18.2-targeted ADCs using PK-Sim® and MoBi®. Read and discover the full article!